Chimeric Antigen Receptor T-Cell Therapies for Cancer

Description

From patient referral to post-therapy management, Chimeric Antigen Receptor (CAR) T-Cell Therapies for Cancer: A Practical Guide presents a comprehensive view of CAR modified T-cells in a concise and practical format. Providing authoritative guidance on the implementation and management of CAR T-cell therapy from Drs. Daniel W. Lee and Nirali N. Shah, this clinical resource keeps you up to date on the latest developments in this rapidly evolving area.

Key Features

• Covers all clinical aspects, including patient referral, toxicities management, comorbidities, bridging therapy, post-CAR monitoring, and multidisciplinary approaches to supportive care.
• Includes key topics on associated toxicities such as predictive biomarkers, infections, and multidisciplinary approaches to supportive care.
• Presents current knowledge on FDA approved CAR T-cell products as well as developments on the horizon.
• Editors and authors represent leading investigators in academia and worldwide pioneers of CAR therapy.

Companion Products

• Chimeric Antigen Receptor T-Cell Therapies for Cancer E-Book : Chimeric Antigen Receptor T-Cell Therapies for Cancer E-Book

Table of Contents

• View Table of Contents

Author Information

Edited by Daniel W. Lee and Nirali N. Shah, Lasker Clinical Research Scholar, Pediatric Oncology Branch, National Cancer Institute, Bethesda, Maryland, United States